Phase IIb study of milciclib in combination with the standard of care treatment sorafenib in patients with hepatocellular carcinoma
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Milciclib (Primary) ; Sorafenib
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Dec 2017 Planned initiation date changed to 1 Apr 2018.
- 11 Dec 2017 According to a Tiziana Life Sciences media release, this trial is expected to begin in in Q2, 2018.
- 21 Jul 2017 New trial record